Summary
PHARMANN is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.17M and a net result of €135k. Equity is growing by ~11.7% per year across the filed fiscal years. Its solvency ranks better than 78% of 5547 sector peers (fiscal year 2025). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 17-10-2025, 14 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
14 d early
2024
27 d early
2023
8 d early
2022
32 d early
2021
54 d early
2020
31 d early
2019
31 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close26-09-2026 today31-10-2026 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file What changed in the latest annual accounts?What changed What held for this company on a given day: board, seat, name?Company as of a date Which other companies resemble this one?Lookalike companies
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€1.17M▲ 13.0%
2024 · €1.03M
Net result
€135k▲ 28.7%
2024 · €105k
Total assets
€1.42M▲ 4.8%
2024 · €1.35M
Solvency
82.3%▲ 6.0pp
2024 · 76.4%
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€156k▲ 17.4%€142k▼ 8.9%€144k▲ 1.6%€158k▲ 9.2%€203k▲ 29.0%
Net result€102k▲ 19.9%€94k▼ 8.4%€91k▼ 2.5%€105k▲ 14.6%€135k▲ 28.7%
Equity€745k▲ 15.9%€838k▲ 12.6%€930k▲ 10.9%€1.03M▲ 11.2%€1.17M▲ 13.0%
Total assets€1.37M▲ 0.8%€1.29M▼ 5.8%€1.31M▲ 1.1%€1.35M▲ 3.5%€1.42M▲ 4.8%
Debt€628k▼ 12.6%€456k▼ 27.5%€379k▼ 16.9%€320k▼ 15.4%€251k▼ 21.6%
Working capital€-192k▲ 25.9%€-99k▲ 48.6%€6k€53k▲ 795%€21k▼ 60.1%
Solvency54.2%▲ 7.1pp64.8%▲ 10.5pp71.1%▲ 6.3pp76.4%▲ 5.3pp82.3%▲ 6.0pp
Staff (FTE)00
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 29% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.42M
Fixed assets
€1.25M ▲ 3.4%
Current assets
€172k ▲ 16.3%
Equity and liabilities €1.42M
Equity
€1.17M ▲ 13.0%
Debt
€251k ▼ 21.6%
Debt's share of the balance-sheet total falls from 23.6% to 17.7%. Equity is higher and debt is lower.
Key figures and ratios
ROE
11.5%▲
2024 · 10.1%
ROA
9.5%▲
2024 · 7.7%
Debt ≤ 1 year
€150k▲
2024 · €94k
Debt > 1 year
€92k▼
2024 · €220k
Income taxes
€59k▲
2024 · €43k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €19k | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €32k | €36k | €36k | €30k | €46k | ▲ 55.4% |
| Other operating charges640/8 | - | €4k | €4k | €4k | €4k | ▼ 1.7% |
| Non-recurring operating charges66A | - | - | - | €53 | €53 | = |
| Gross operating margin9900 | €192k | €182k | €185k | €192k | €254k | ▲ 32.4% |
| Operating profit (loss)9901 | €156k | €142k | €144k | €158k | €203k | ▲ 29.0% |
| Financial income75/76B | - | €0 | €1 | €647 | €638 | ▼ 1.5% |
| Recurring financial income75 | €0 | €0 | €1 | €647 | €638 | ▼ 1.5% |
| Financial charges65/66B | - | €9k | €9k | €10k | €11k | ▲ 4.3% |
| Recurring financial charges65 | €11k | €9k | €9k | €10k | €11k | ▲ 4.3% |
| Profit (loss) for the period before taxes9903 | €145k | €133k | €136k | €148k | €193k | ▲ 30.6% |
| Income taxes67/77 | €43k | €40k | €44k | €43k | €59k | ▲ 35.2% |
| Profit (loss) for the period9904 | €102k | €94k | €91k | €105k | €135k | ▲ 28.7% |
| Profit (loss) for the period to be appropriated9905 | €102k | €94k | €91k | €105k | €135k | ▲ 28.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.37M | €1.29M | €1.31M | €1.35M | €1.42M | ▲ 4.8% |
| Fixed assets21/28 | €1.24M | €1.20M | €1.17M | €1.21M | €1.25M | ▲ 3.4% |
| Tangible fixed assets22/27 | €476k | €441k | €405k | €443k | €485k | ▲ 9.4% |
| Land and buildings22 | - | €405k | €389k | €390k | €373k | ▼ 4.3% |
| Furniture and vehicles24 | - | €36k | €16k | €53k | €111k | ▲ 109% |
| Financial fixed assets28 | €764k | €764k | €764k | €764k | €764k | = |
| Current assets29/58 | €134k | €89k | €140k | €147k | €172k | ▲ 16.3% |
| Amounts receivable within one year40/41 | €20k | €17k | €17k | €34k | €40k | ▲ 16.3% |
| Trade receivables40 | - | €17k | €17k | €27k | €40k | ▲ 47.8% |
| Other amounts receivable41 | - | €9 | €10 | €7k | €0 | ▼ 100% |
| Current investments50/53 | - | - | €13k | €13k | €26k | ▲ 104% |
| Cash at bank and in hand54/58 | €111k | €69k | €107k | €98k | €101k | ▲ 3.2% |
| Deferred charges and accrued income490/1 | - | €3k | €3k | €3k | €5k | ▲ 72.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.37M | €1.29M | €1.31M | €1.35M | €1.42M | ▲ 4.8% |
| Equity10/15 | €745k | €838k | €930k | €1.03M | €1.17M | ▲ 13.0% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | €726k | €820k | €911k | €1.02M | €1.15M | ▲ 13.3% |
| Non-distributable reserves130/1 | - | €0 | - | - | - | - |
| Reserves not available under the articles1311 | - | €0 | - | - | - | - |
| Distributable reserves133 | - | €820k | €911k | €1.02M | €1.15M | ▲ 13.3% |
| Amounts payable17/49 | €628k | €456k | €379k | €320k | €251k | ▼ 21.6% |
| Amounts payable after more than one year17 | €294k | €266k | €243k | €220k | €92k | ▼ 58.2% |
| Financial debts170/4 | - | €161k | €138k | €115k | €92k | ▼ 20.0% |
| Other amounts payable178/9 | - | €105k | €105k | €105k | €0 | ▼ 100% |
| Amounts payable within one year42/48 | €326k | €188k | €134k | €94k | €150k | ▲ 59.8% |
| Current portion of amounts payable after more than one year42 | - | €28k | €23k | €23k | €23k | = |
| Trade debts44 | €3k | €4k | €2k | €14k | €4k | ▼ 74.0% |
| Suppliers440/4 | - | €4k | €2k | €14k | €4k | ▼ 74.0% |
| Taxes, remuneration and social security45 | - | €18k | €14k | €20k | €28k | ▲ 42.8% |
| Taxes450/3 | - | €16k | €14k | €18k | €24k | ▲ 34.9% |
| Remuneration and social security454/9 | - | €2k | €0 | €2k | €5k | ▲ 103% |
| Other amounts payable47/48 | - | €138k | €94k | €37k | €95k | ▲ 158% |
| Accrued charges and deferred income492/3 | - | €2k | €2k | €6k | €9k | ▲ 44.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €102k | €94k | €91k | €105k | €135k | ▲ 28.7% |
| + Depreciation and write-downs630 | €32k | €36k | €36k | €30k | €46k | ▲ 55.4% |
| Operating cash flow (approximation) | €134k | €130k | €128k | €134k | €181k | ▲ 34.6% |
| Investment in fixed assets (approximation) | - | €-1k | €0 | €-68k | €-87k | ▼ 28.6% |
| Change in cash | - | €-42k | €37k | €-9k | €3k | ▲ 134% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
17-10
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
31-03
Financial
Highest result since 2019net €135k ▲28.7%
Operating result €203k, net result €135k, both a record.
2024
04-10
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
31-03
Financial
Equity above €1MEq €1.03M ▲11.2%
6 profitable years in a row build equity to €1.03M.
2023
23-10
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
31-03
Financial
Liquidity doublescurrent ratio 1.04
Current ratio from 0.47 to 1.04; short-term debt falls from €188k to €134k.
2022
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
07-09
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2020
30-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2019
30-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
01-10
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
31-10
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
20-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kuurne · 1 establishment unit since 2012
Ground area
1,279 m²
Building footprint
252 m²
Volume, LiDAR
2,114 m³
Parcel 34023C0333/00H002, Flanders · tallest building 15.1 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
PHARMANN
since 20122.209.899.926
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34023C0333/00H002 | Flanders | 1,279 m² | 1 · 252 m² | 15.1 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LLN HOLDING
BE 0678.530.143
Zottegem · Eq €1,168,983
GROUP-DEL
BE 0878.447.638
Roeselare · Eq €1,169,336
FOR LIVING
BE 0878.614.221
Westerlo · Eq €1,169,700
VIATTECH INVEST
BE 0760.453.175
Brussel · Eq €1,167,858
AL2gether
BE 0797.949.318
Ronse · Eq €1,170,026
Of 24,730 companies in sector 64210 we hold annual accounts for 19,772. 12,323 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-05-2012
Fiscal year end31-03
Activities, NACEBEL 2025
64210Activities of holding companies
Contact
E-mail
ann.vercruysse@telenet.be
Phone
0478 704 274
Scores and ratios are computed by Checked and are not a credit decision.